7 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... GLP-1 receptor agonists ... #medications #table ... endocrinology #dm2
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
some Cholinergic Agonists ... • Used as an antidote ... • Used as an antidote ... #Cholinergic #Agonists ... #Pharmacology #Table
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... Ozempic), or daily tablet ... GLP1 #Receptor #Agonists ... Pharmacology #Summary #DM2
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... Tradjenta) - Once/day tablet ... GLP-I receptor agonist ... Pharmacology #Summary #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
GLP-1 receptor agonist ... Diabetes #Mellitus #DM2 ... pharmacology #comparison #table
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... high-affinity, partial agonist ... If patient is stable ... Buprenorphine #Treatment #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... Insulin dependent DM ... event, follow ACC algorithm ... Stable patients